• Media type: E-Article
  • Title: A novel synonymous homozygous variant [c.2538GA (p.Thr846Thr)] in TRPM6 in a patient with hypomagnesemia with secondary hypocalcemia
  • Contributor: Acar, Sezer; Schlingmann, Karl Peter; Nalbantoğlu, Özlem; Köprülü, Özge; Arslan, Gülçin; Özkaya, Beyhan; Özkan, Behzat
  • Published: Walter de Gruyter GmbH, 2021
  • Published in: Journal of Pediatric Endocrinology and Metabolism, 34 (2021) 11, Seite 1481-1486
  • Language: English
  • DOI: 10.1515/jpem-2021-0165
  • ISSN: 2191-0251; 0334-018X
  • Keywords: Endocrinology ; Endocrinology, Diabetes and Metabolism ; Pediatrics, Perinatology and Child Health
  • Origination:
  • Footnote:
  • Description: Abstract Objectives Hypomagnesemia 1, intestinal (HOMG1) is characterized by neurological symptoms that occur due to hypocalcemia and hypomagnesemia and caused by mutations in the TRPM6. Most of the identified variants in TRPM6 lead to premature termination: nonsense, frameshift, deletion, and splice site mutations. Case presentation Herein, we report a 1.5 month-old case who presented with convulsion due to hypocalcemia and hypomagnesemia in the early infancy. Sequencing of TRPM6 revealed a novel homozygous synonymous variant [c.2538G > A (p.Thr846Thr)] in the last codon of exon 19, which is most likely to affect the splicing. We report a novel homozygous synonymous variant in the TRPM6 leading to HOMG1, expanding the mutational spectrum. Conclusions Synonymous mutations that were previously considered as harmless should be evaluated at the nucleotide level, keeping in mind that they may affect splicing and cause to the disease.